Sarah Bevington, PhD

Dr. Sarah Bevington is a QC scientist at Labcorp Biopharmaceutical CMC Services in the molecular biology and virology department. In this role, Sarah is responsible for a wide range of GLP and GCP studies at all stages of development using molecular biology techniques such as qPCR and ddPCR. She works closely with clients to deliver assays that are fit for purpose and are compliant with regulatory guidelines.

Prior to taking up her position at Labcorp, Sarah worked as a postdoctoral research fellow at the University of Birmingham where she studied the molecular mechanisms and transcriptional regulation of immune cells, focusing on how changes in the epigenetic landscape control these processes in T-cells. In her PhD research at the University of Leeds, she also studied the epigenetic regulation of immune cell processes, looking into how V(D)J recombination is regulated in B-cells.